A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1994
11/30/1994	EP0626390A1 Humanised antibodies
11/30/1994	EP0626389A1 Recombinant antibodies specific for TNF-alpha
11/30/1994	EP0626170A2 Stabilisation of pharmacologically active compounds in sustained release compositions
11/30/1994	EP0626169A2 A dosage form comprising an antigen and a salt form of an organic acid derivative of a sterol
11/30/1994	EP0626013A1 RECOMBINANT $g(b)-LACTAMASE USABLE AS CARRIER MOLECULE FOR THE PREPARATION OF IMMUNOGENIC COMPOSITIONS
11/30/1994	EP0626008A1 Vaccine containing acemannan as an adjuvant
11/30/1994	EP0625993A1 Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
11/30/1994	EP0625990A1 Glycoprotein complexes and glycoproteins
11/30/1994	EP0625989A1 Dna sequences encoding novel growth/differentiation factors
11/30/1994	EP0625910A1 Dual carrier immunogenic construct
11/30/1994	EP0625907A1 Chimeric mammals with human hematopoietic cells
11/30/1994	EP0509008B1 Biomass for the production of viruses/virus antigens
11/30/1994	EP0422164B1 Large multivalent immunogen
11/30/1994	EP0191813B1 Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
11/30/1994	CN1095597A Antihydrophobia immune plasma and its prepn. tech.
11/29/1994	US5369026 DNA encoding bovine coronavirus polypeptides E2 and E3
11/29/1994	US5369025 Recombinant fowlpox vaccine for protection against Marek's disease
11/29/1994	US5369019 Genetic engineering
11/29/1994	US5369005 Method for mycoplasma detection in a biological sample
11/29/1994	US5368855 Pox virus vaccine
11/29/1994	CA2124027A1 Dna originating in a non-a non-b hepatitis virus gene and constituting polypeptide
11/29/1994	CA1333265C Coupling agents for radiolabeling proteins
11/29/1994	CA1333258C Transmucosal formulations
11/29/1994	CA1333257C Use of zinc hydroxide or iron hydroxide as adjuvant in antigen solutions, and antigen solutions containing such adjuvants
11/29/1994	CA1333256C Hyposensitization agent
11/24/1994	WO1994027156A1 Assay for cardiac troponin i
11/24/1994	WO1994027153A1 Methods of typing hepatitis c virus and reagents for use therein
11/24/1994	WO1994026925A2 Processes for producing an enzyme
11/24/1994	WO1994026923A1 Method for recombinant production of biologically active polypeptides
11/24/1994	WO1994026914A1 Adenoviral vectors of animal origin and use thereof in gene therapy
11/24/1994	WO1994026910A1 Immunotoxins comprising gelonin and an antibody
11/24/1994	WO1994026904A1 Hepatitis b virus mutants, reagents and methods for detection
11/24/1994	WO1994026903A2 Human influenza virus peptides binding hla-i molecule
11/24/1994	WO1994026902A1 Nucleic acids encoding human astrovirus serotype 2 and uses thereof
11/24/1994	WO1994026901A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
11/24/1994	WO1994026900A2 Hybrid picornaviruses expressing chlamydial epitopes
11/24/1994	WO1994026899A1 Method for the culture in vitro of differents stages of tissue parasites
11/24/1994	WO1994026891A2 Purified mammalian flt3 ligands and agonists and antagonists thereof
11/24/1994	WO1994026886A2 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable
11/24/1994	WO1994026785A1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
11/24/1994	WO1994026784A1 Composition of antibodies against hepatitis b surface antigen
11/24/1994	WO1994026776A1 Therapeutic compounds
11/24/1994	WO1994026773A1 Regulation of antigen presentation
11/24/1994	WO1994026754A1 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation
11/24/1994	WO1994026312A1 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN inhA GENE
11/24/1994	WO1994026308A1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins
11/24/1994	WO1994026307A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
11/24/1994	WO1994026306A1 Conserved motif of hepatitis c virus e2/ns1 region
11/24/1994	WO1994026305A1 Hiv immunogenic complexes
11/24/1994	WO1994026304A1 Otitis media vaccine
11/24/1994	WO1994026303A1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
11/24/1994	WO1994026298A1 Methods for treating muscle diseases and disorders
11/24/1994	WO1994026297A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
11/24/1994	WO1994026289A1 Allogeneic and xenogeneic transplantation
11/24/1994	WO1994026285A1 Xenograft thymus
11/24/1994	WO1994023035A3 Recombinant timothy grass pollen allergen phl p ii
11/24/1994	WO1994019466A3 A novel family of anti-carcinoembryonic antigen chimeric antibodies
11/24/1994	CA2555020A1 Inhibition of migration of inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
11/24/1994	CA2163105A1 Purified mammalian flt3 ligands and agonists and antagonists thereof
11/24/1994	CA2162868A1 Methods and compositions for detecting and treating mycobacterial infections using an inha gene
11/24/1994	CA2162865A1 Method for recombinant production of biologically active polypeptides
11/24/1994	CA2162664A1 Hybrid picornaviruses expressing chlamydial epitopes
11/24/1994	CA2162370A1 Composition of antibodies against hepatitis b surface antigen
11/24/1994	CA2162121A1 Assay for cardiac troponin i
11/24/1994	CA2162022A1 Processes for producing an enzyme
11/24/1994	CA2161797A1 Xenograft thymus
11/23/1994	EP0625212A1 Methods of detecting alzheimer's disease
11/23/1994	EP0625207A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr)
11/23/1994	EP0625204A1 Hepatitis therapeutics
11/23/1994	EP0625203A1 Synthetic haemophilus influenzae conjugate vaccine
11/23/1994	EP0625201A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
11/23/1994	EP0625200A1 Biosynthetic binding protein for cancer marker
11/23/1994	EP0625165A1 Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis
11/23/1994	EP0625053A1 Urease-based vaccine against helicobacter infection
11/23/1994	EP0625052A1 Bacterial expression vectors containing dna encoding secretion signals of lipoproteins
11/23/1994	EP0625049A1 Ex vivo gene transfer
11/23/1994	EP0625047A1 Platelet transfusion
11/23/1994	EP0625043A1 Recombinant multivalent m protein vaccine
11/23/1994	EP0625007A1 Gene transfer in birds by introduction of dna into muscle in ovo
11/23/1994	EP0464101B1 Improvements relating to the radio-labelling of proteins
11/22/1994	US5367059 Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor
11/22/1994	US5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/22/1994	US5366728 Vaccines for immunology of ruminants
11/22/1994	CA1333152C Vaccine containing tumor antigens and adjuvants
11/17/1994	EP0624377A2 Lysosomal enzyme-cleavable antitumor drug conjugates
11/17/1994	EP0624376A1 Preparation and uses of LOS-depleted outer membrane proteins of gram-negative cocci
11/17/1994	EP0624201A1 Method for producing soluble t-receptors by co-transfection, and use of resulting products
11/17/1994	EP0624198A1 Synthetic peptides for a rubella vaccine
11/17/1994	EP0624195A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
11/17/1994	EP0624188A1 Novel adherent and invasive mycoplasma
11/17/1994	EP0624100A1 Dna encoding a human serotonin receptor (5-ht 4b?) and uses thereof
11/17/1994	EP0624088A1 Amino acids useful as inhibitors of the advanced glycosylation of proteins
11/17/1994	EP0109441B1 Human-human hybridomas for neoplasms
11/16/1994	CN1095106A Vaccines
11/16/1994	CN1094965A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
11/15/1994	US5364933 Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2)
11/15/1994	US5364837 Follicle stimulating hormone for producing antibodies
11/15/1994	US5364793 Methods for the diagnosis of peripheral nerve damage
11/15/1994	US5364774 Isolation of polynucleotides like DNA, hybridization and degeneration
11/15/1994	US5364773 Vaccinia virus with deletions; safety

1 ... 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 ... 1823